Stocks · Korea
067080
KOSDAQ
DAE HWA Pharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER129.04x
PBR2.93x
EPS94 KRW
BPS4,138 KRW
ROE2.78%
Dividend yield1.24%
DPS150 KRW
Payout ratio159.57%
Returns and 52-week range
1W+5.20%
1M+14.43%
3M+31.14%
6M-18.48%
1Y-15.76%
YTD-32.08%
52W high24,900원
52W low7,460원
From 52W high-51.29%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,319억 | 58억 | 12억 | 4.4% |
| 2023 | 1,414억 | 20억 | -5억 | 1.4% |
| 2024 | 1,494억 | 67억 | 8억 | 4.5% |
| 2025 | 1,431억 | 32억 | 23억 | 2.2% |
| Quarterly | ||||
| 2024 4Q | 401억 | 34억 | 14억 | 8.6% |
| 2025 1Q | 367억 | 11억 | -3억 | 3.1% |
| 2025 2Q | 360억 | 3억 | -5억 | 0.8% |
| 2025 3Q | 367억 | 10억 | -2억 | 2.9% |
| 2025 4Q | 337억 | 7억 | 33억 | 2.1% |
| 2026 1Q | 370억 | 5억 | -3억 | 1.2% |
Company
Address: 강원도 횡성군 횡성읍 한우로 495
Peers in the same sector
Recent filings
- 2026-08-07반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-08-10증시 혼조 속, 대화제약·랩지노믹스·네오이뮨텍↑ [바이오맥짚기] 이데일리
- 2026-08-05대화제약, 주당 50원 분기 현금배당 결정 아이뉴스24
- 2026-07-14[애프터마켓 리뷰] 李 대통령 '미프진' 언급에 대화제약 등 급등 SBS Biz
- 2026-05-13대화제약 ‘리포락셀액’ 유방암 적응증 확보…치료 영역 확대 이데일리
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.